SOCIETY FOR VASCULAR SURGERY (EIN 222990719) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1947

Legal Domicile

Principal Officer

KENNETH M SLAW PHD

Phone

3123342319

Tax Period

2024-04-01 to 2025-03-31

SOCIETY FOR VASCULAR SURGERY, founded in 1947, is a mid-sized nonprofit that reported $10.1M in total revenue in fiscal year 2017. Expenses of $9.1M left a modest 10% surplus.

Mission

TO PROMOTE VASCULAR HEALTH THROUGH ADVANCING SCIENCE & PRACTICE OF VASCULAR DISEASE MANAGEMENT.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,517,807

Program Service Revenue $12,623,525

Investment Income $832,682

Other Revenue $351,267

TOTAL REVENUE $15,325,281

Expense Breakdown

Grants Paid $205,095

Salaries & Benefits $7,230,586

Fundraising Expenses $0

Other Expenses $9,649,918

TOTAL EXPENSES $17,085,599

Year-over-Year Comparison

	2024	2023	Change
Revenue	$15,325,281	$14,766,161	+0.0%
Expenses	$17,085,599	$14,764,215	+0.2%
Net Income	$-1,760,318	$1,946	-905.6%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

554

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$453,396

Total Directors

Key Employees

$255,548

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KEITH D CALLIGARO MD	PRESIDENT-ELECT	2.00	Officer Director	$0	$0	$0
MATTHEW J EAGLETON MD	PRESIDENT	2.00	Officer Director	$0	$0	$0
ROBERT G MOLNAR MD	AT LRG MEMBER	1.00	Director	$0	$0	$0
BERNADETTE AULIVOLA MD	AT LRG MEMBER	1.00	Director	$0	$0	$0
LINDA M HARRIS MD	VICE PRESIDENT	2.00	Officer Director	$0	$0	$0
WILLIAM P SHUTZE MD	SECRETARY	2.00	Officer Director	$0	$0	$0
KWAME S AMANKWAH MD	AT LRG MEMBER	1.00	Director	$0	$0	$0
KELLIE R BROWN MD	AT LRG MEMBER	1.00	Director	$0	$0	$0
AUDRA A DUNCAN MD	AT LRG MEMBER	1.00	Director	$0	$0	$0
THOMAS L FORBES MD	TREASURER	2.00	Officer Director	$0	$0	$0
JOSEPH L MILLS MD	IMMEDIATE PAST-PRESIDENT	2.00	Officer Director	$0	$0	$0
KENNETH M SLAW PHD	EXECUTIVE DIRECTOR	37.50	Officer	$411,645	$41,751	$453,396
JIM WADZINSKI	DEPUTY EXECUTIVE DIRECTOR	37.50	Key Emp	$243,194	$12,354	$255,548
MEGAN MARCINKO	SENIOR DIRECTOR OF ADVOCAC	37.50	Highest	$206,018	$10,301	$216,319
KEVIN ONORATO	IT DIRECTOR	37.50	Highest	$171,790	$18,934	$190,724
SARAH MURPHY	DIRECTOR OF RESEARCH	37.50	Highest	$171,692	$26,853	$198,545
JANINE DIANA	HUMAN RESOURCES DIRECTOR	37.50	Highest	$143,696	$18,521	$162,217
SHRAVAN ANIMILLI	DIRECTOR OF ANALYTICS AND DATA SCIENCE	37.50	Highest	$144,200	$33,725	$177,925

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$15,325,281	$17,085,599	$27,048,949	$-1,760,318
2024	$14,766,161	$14,764,215	$27,787,589	$1,946
2023	$14,367,638	$13,745,378	$26,706,213	$622,260
2022	$12,701,709	$12,291,878	$23,352,063	$409,831
2021	$15,180,564	$10,274,920	$22,456,711	$4,905,644
2020	$11,971,758	$11,336,895	$16,403,305	$634,863
2019	$10,423,194	$10,297,577	$17,231,554	$125,617
2018	$10,137,051	$9,106,154	$16,479,933	$1,030,897

SOCIETY FOR VASCULAR SURGERY